Neumora Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Neumora Therapeutics Inc had 147.07M in cash and cash equivalents.

Neumora Therapeutics Inc reported 87.18M in total liabilities as of the latest reported quarter, including 32.45M in current liabilities and 54.73M in non-current liabilities.

As of the latest reported quarter, Neumora Therapeutics Inc's total assets were 191.05M, consisting of 190.54M in current assets and 510.00K in non-current assets.

Neumora Therapeutics Inc reported 103.87M in total shareholders' equity as of the latest reported quarter.